Technology Agency of the Czech Republic
Martin Bunček graduated from University of Pardubice, Faculty of Chemical Technology. Completed postgraduate studies at the Pharmaceutical Faculty of the Charles University and a work stay at IMM in Oxford and TUe in Eindhoven. He worked for GENERI BIOTECH almost since its foundation, gradually went through all the positions and participated in the conception of the company as a whole, especially in R&D. He held the managerial position of R&D Director at GENERI BIOTECH Ltd. Principal investigator or co-worker of national and international (FP6, FP7 EU) projects. He is dealing with external teaching: till 02/2014 as an assistant professor at the University of Pardubice, Faculty of Chemical Technology, lectures molecular biology and genetics and molecular biological methods, at Charles University, Faculty of Pharmacy in gene therapy. Gained experience not only in the protection of R&D results (patents, etc.), application of R&D results in practice, but also purchasing and use of know-how, including the due-diligence. In GENERI BIOTECH Ltd. successfully led negotiations on the purchase of a license from the Masaryk University, under which a unique diagnostic kit for determining the prognosis of chronic lymphocytic leukemia was developed and is marketed. He actively participated in the initiation and initial development of the association of Czech biotech companies CzechBio.
He has worked for the Technology Agency of the Czech Republic since its foundation in 2009 as a member of the board and the vice-chairman. Since 2018 he has been managing director of the Technology Agency of the Czech Republic.